Opioids and Their Receptors : Present and Emerging Concepts in Opioid Drug Discovery

The interest in opioids such as morphine, the prototypical opioid ligand, has been maintained through the years. The identification of endogenous opioids and their receptors (mu, delta, kappa, and nociceptin), molecular cloning, and the elucidation of the crystal structures of opioid receptors repre...

Full description

Saved in:
Bibliographic Details
HerausgeberIn:
Sonstige:
Year of Publication:2020
Language:English
Physical Description:1 electronic resource (358 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 06520nam-a2201717z--4500
001 993546109004498
005 20231214132947.0
006 m o d
007 cr|mn|---annan
008 202105s2020 xx |||||o ||| 0|eng d
035 |a (CKB)5400000000040967 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/69428 
035 |a (EXLCZ)995400000000040967 
041 0 |a eng 
100 1 |a Spetea, Mariana  |4 edt 
245 1 0 |a Opioids and Their Receptors  |b Present and Emerging Concepts in Opioid Drug Discovery 
246 |a Opioids and Their Receptors  
260 |a Basel, Switzerland  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2020 
300 |a 1 electronic resource (358 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
520 |a The interest in opioids such as morphine, the prototypical opioid ligand, has been maintained through the years. The identification of endogenous opioids and their receptors (mu, delta, kappa, and nociceptin), molecular cloning, and the elucidation of the crystal structures of opioid receptors represent key milestones in opioid research. The opioid system modulates numerous pharmacological responses, with therapeutic (i.e., analgesia) and detrimental side effects (i.e., addiction). The medical use and misuse of opioids have dramatically increased, leading to the 21st century opioid crisis. This book presents recent developments in opioid drug discovery, specifically in the medicinal chemistry and pharmacology of new ligands targeting the opioid receptors as effective and safe therapeutics for human diseases. Furthermore, it draws a special attention to advancing concepts and strategies in opioid drug discovery to mitigate opioid liabilities. The diversity among the discussed topics is a testimony to the complexity of the opioid system, which results from the expression, regulation, and functional role of ligands and receptors. The array of multidisciplinary research areas illustrates the rapidly developing basic research and translational activities in opioid drug discovery. This book will serve as a useful reference while also stimulating continued research in the chemistry and pharmacology of opioids and their receptors, with the prospect of developing improved therapies for human diseases, but also improving health and quality of life in general. 
546 |a English 
650 7 |a Medicine  |2 bicssc 
653 |a opioid receptors 
653 |a neurokinin-1 receptor 
653 |a peptide synthesis 
653 |a receptor binding studies 
653 |a functional assay 
653 |a writhing test 
653 |a tolerance 
653 |a Leu-enkephalin 
653 |a beta-arrestin 
653 |a mu opioid receptor 
653 |a delta opioid receptor 
653 |a biased signaling 
653 |a DADLE 
653 |a ischemia 
653 |a plasma stability 
653 |a morphinan 
653 |a BNTX 
653 |a δ opioid receptor antagonist 
653 |a 1H-NMR experiments 
653 |a mechanism elucidation 
653 |a peripheral antinociception 
653 |a 14-methoxycodeine-6-O-sulfate 
653 |a codeine-6-O-sulfate 
653 |a opioid peptides and peptidomimetics 
653 |a DAMGO 
653 |a DALDA 
653 |a [Dmt1]DALDA 
653 |a KGOP01 
653 |a binding 
653 |a molecular docking 
653 |a structure-activity relationships 
653 |a β2-amino acids 
653 |a β2-Homo-amino acids 
653 |a µ-opioid receptor 
653 |a opioid peptides 
653 |a TAPP 
653 |a racemic synthesis of β2-amino acids 
653 |a peripheral µ-opioid receptors 
653 |a analgesia 
653 |a peripheral analgesic tolerance 
653 |a dysbiosis 
653 |a opioid 
653 |a bifunctional ligands 
653 |a (−)-N-phenethylnorhydromorphone analogs 
653 |a [35S]GTPgammaS assay 
653 |a forskolin-induced cAMP accumulation assays 
653 |a β-arrestin recruitment assays 
653 |a MOR and DOR agonists 
653 |a respiratory depression 
653 |a bias factor 
653 |a molecular modeling &amp 
653 |a simulation 
653 |a δ opioid receptor 
653 |a NTI derivative 
653 |a sulfonamide 
653 |a inverse agonist 
653 |a neutral antagonist 
653 |a agonist 
653 |a opioids 
653 |a mu receptor 
653 |a opioid side effects 
653 |a biased agonism 
653 |a partial agonism 
653 |a zerumbone 
653 |a chronic constriction injury (CCI) 
653 |a allodynia 
653 |a hyperalgesia 
653 |a potassium channels 
653 |a over-the-counter drugs 
653 |a misuse 
653 |a abuse 
653 |a opioid drugs 
653 |a pharmacology 
653 |a codeine 
653 |a dihydrocodeine 
653 |a loperamide 
653 |a opioid peptide 
653 |a macrocyclic tetrapeptide 
653 |a multifunctional ligands 
653 |a kappa opioid receptor 
653 |a analgesics 
653 |a opioid liabilities 
653 |a μ opioid receptor 
653 |a receptor model 
653 |a biased ligands 
653 |a dependence 
653 |a pain therapy 
653 |a neonatal opioid withdrawal syndrome 
653 |a naltrexone 
653 |a 6β-naltrexol 
653 |a buprenorphine 
653 |a G-protein bias 
653 |a arrestin recruitment 
653 |a respiration 
653 |a mitragynine 
653 |a heteromer 
653 |a internalization 
653 |a primary hippocampal culture 
653 |a lysosomes 
653 |a µ opioid receptor 
653 |a molecular dynamics 
653 |a docking 
653 |a interaction fingerprints 
653 |a biased agonists 
653 |a SR-17018 
653 |a PZM21 
653 |a morphine 
653 |a fentanyl 
653 |a diphenethylamines 
653 |a design and synthesis 
653 |a structure-activity relationships 
653 |a partial agonist 
653 |a biased agonist 
653 |a antagonist 
653 |a binding affinity 
653 |a selectivity 
776 |z 3-0365-0046-4 
776 |z 3-0365-0047-2 
700 1 |a Schmidhammer, Helmut  |4 edt 
700 1 |a Spetea, Mariana  |4 oth 
700 1 |a Schmidhammer, Helmut  |4 oth 
906 |a BOOK 
ADM |b 2023-12-15 05:38:04 Europe/Vienna  |f system  |c marc21  |a 2022-04-04 09:22:53 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338115250004498&Force_direct=true  |Z 5338115250004498  |b Available  |8 5338115250004498